Inventor · disambiguated record
Ivan Viktorovich Efremov
Also filed as: EFREMOV IVAN · EFREMOV IVAN V · EFREMOV IVAN VIKTOROVICH
31 granted patents·15 pending applications·177 citations·filing 2007–2024
97Inventor score
Files withPFIZER31CYSTIC FIBROSIS FOUND5CYSTIC FIBROSIS FOUND THERAPEUTICS INC4FULCRUM THERAPEUTICS INC4BRODNEY MICHAEL AARON1
Top patents by PatentIndex Score
46 records- 0196US10208053B2Bicyclic heteroaryl derivatives as CFTR potentiatorsCYSTIC FIBROSIS FOUND THERAPEUTICS INC·Filed 2018·Granted Feb 19, 2019·31 cites·19 claims
- 0295US10131670B2Bicyclic heteroaryl derivatives as CFTR potentiatorsCYSTIC FIBROSIS FOUND THERAPEUTICS INC·Filed 2017·Granted Nov 20, 2018·27 cites·8 claims
- 0395US9663526B2Aminopyrimidinyl compoundsPFIZER·Filed 2015·Granted May 30, 2017·22 cites·26 claims
- 0494US10973805B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2020·Granted Apr 13, 2021·5 cites·20 claims
- 0594US9107923B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Aug 18, 2015·11 cites·30 claims
- 0693US9527831B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2014·Granted Dec 27, 2016·13 cites·30 claims
- 0793US9139561B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Sep 22, 2015·8 cites·30 claims
- 0892US11197867B2Aminopyrimidinyl compoundsPFIZER·Filed 2020·Granted Dec 14, 2021·2 cites·9 claims
- 0991US11590111B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·2 cites·10 claims
- 1091US9822097B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2016·Granted Nov 21, 2017·6 cites·15 claims
- 1190US8822494B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2013·Granted Sep 2, 2014·12 cites·54 claims
- 1289US9688698B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Jun 27, 2017·4 cites·20 claims
- 1389US2024317713A1Heteroaromatic compounds and their use as dopamine d1 ligandsPFIZER·Filed 2024·Application pending·0 cites
- 1487US9617275B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Apr 11, 2017·5 cites·18 claims
- 1587US9133190B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2014·Granted Sep 15, 2015·8 cites·60 claims
- 1686US10463675B2Aminopyrimidinyl compoundsPFIZER·Filed 2017·Granted Nov 5, 2019·4 cites·2 claims
- 1786US10093655B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2017·Granted Oct 9, 2018·3 cites·20 claims
- 1885US10980815B2Aminopyrimidinyl compoundsPFIZER·Filed 2019·Granted Apr 20, 2021·2 cites·8 claims
- 1984US10421744B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2018·Granted Sep 24, 2019·2 cites·20 claims
- 2083US10301315B2Pyrrolopyrimidines as CFTR potentiatorsCYSTIC FIBROSIS FOUND THERAPEUTICS INC·Filed 2017·Granted May 28, 2019·1 cites·20 claims
- 2183US2025195480A1Macrocyclic azolopyridine derivatives as eed and prc2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2282US9527843B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Dec 27, 2016·3 cites·14 claims
- 2381US12109198B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2022·Granted Oct 8, 2024·0 cites·5 claims
- 2481US10494374B2Pyrrolopyrimidines as CFTR potentiatorsCYSTIC FIBROSIS FOUND·Filed 2019·Granted Dec 3, 2019·1 cites·67 claims
- 2579US10377762B2Bicyclic heteroaryl derivatives as CFTR potentiatorsCYSTIC FIBROSIS FOUND THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·1 cites·15 claims
- 2679US9856263B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Jan 2, 2018·2 cites·16 claims
- 2777US11964961B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2021·Granted Apr 23, 2024·0 cites·20 claims
- 2877US2023250100A1Pyrrolopyrimidines as CFTR PotentiatorsCYSTIC FIBROSIS FOUND·Filed 2023·Application pending·0 cites
- 2974US11014909B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2020·Granted May 25, 2021·0 cites·22 claims
- 3074US10696658B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2019·Granted Jun 30, 2020·0 cites·13 claims
- 3174US2021377495A1Aminopyrimidinyl compoundsPFIZER·Filed 2021·Application pending·0 cites
- 3272US2020017512A1Pyrrolopyrimidines as cftr potentiatorsCYSTIC FIBROSIS FOUND·Filed 2019·Application pending·0 cites
- 3371US9868744B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Jan 16, 2018·1 cites·14 claims
- 3469US2021171534A1Pyrrolopyrimidines as CFTR PotentiatorsCYSTIC FIBROSIS FOUND·Filed 2021·Application pending·0 cites
- 3566US9745317B2Heterocyclic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Aug 29, 2017·1 cites·22 claims
- 3665US10766904B2Bicyclic heteroaryl derivatives as CFTR potentiatorsCYSTIC FIBROSIS FOUND·Filed 2019·Granted Sep 8, 2020·0 cites·1 claims
- 3762US2017165270A1Heteroaromatic Compounds and their Use as Dopamine D1 LigandsPFIZER·Filed 2017·Application pending·0 cites
- 3862US2015291625A1Heteroaromatic Compounds and their Use as Dopamine D1 LigandsPFIZER·Filed 2013·Application pending·0 cites
- 3960US2018200253A1Heteroaromatic Compounds and their Use as Dopamine D1 LigandsPFIZER·Filed 2018·Application pending·0 cites
- 4057US2018346477A1Heteroaromatic compounds and their use as dopamine d1 ligandsPFIZER·Filed 2018·Application pending·0 cites
- 4156US10077272B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2017·Granted Sep 18, 2018·0 cites·19 claims
- 4253US2011224231A1Novel Lactams as Beta Secretase InhibitorsPFIZER·Filed 2009·Application pending·0 cites
- 4350US2009137577A1Heterocyclic compoundsPFIZER·Filed 2008·Application pending·0 cites
- 4448US2008312271A1Azabenzimidazolyl compoundsPFIZER·Filed 2007·Application pending·0 cites
- 4548US2008280933A1Benzimidazolyl compoundsEFREMOV IVAN·Filed 2007·Application pending·0 cites
- 4637US2013150376A1Novel Sultam CompoundsBRODNEY MICHAEL AARON·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ivan Viktorovich Efremov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →